Category | Disorder | Pathophysiology | Core clinical features | Clues and distinguishing features from PD |
Prominent tremor | Essential tremor | Not well characterized |
|
|
Atypical parkinsonian disorders | Dementia with Lewy bodies | Synucleinopathy |
|
|
Multiple system atrophy | Synucleinopathy; oligodendroglial alpha-synuclein aggregation |
|
| |
Progressive supranuclear palsy | Tauopathy; tau-positive deposits in neurons and glia of basal ganglia, brainstem, cerebellum, and cortex |
|
| |
Corticobasal degeneration | Tauopathy; tau-positive deposits in neurons and glia of cortex and striatum |
|
| |
Other neurodegenerative disorders | Idiopathic and familial basal ganglia calcification | Calcium deposits in basal ganglia; multiple causative genes |
|
|
Huntington disease | CAG repeat expansion in the HTT gene; toxic gain-of-function mechanism due to mutant huntingtin protein |
|
| |
Frontotemporal dementia with parkinsonism | Tauopathy; pathogenic variant in the MAPT gene on chromosome 17 |
|
| |
Spinocerebellar ataxia | >40 genetic causes |
|
| |
Secondary parkinsonism | Causes | Examples | ||
Drug-induced | Antipsychotic agents, metoclopramide, prochlorperazine, tetrabenazine, valproic acid | |||
Vascular | Vascular parkinsonism, vascular dementia | |||
Toxic | Carbon disulfide, carbon monoxide, cyanide, MPTP, manganese, organic solvents | |||
Metabolic | Hypoparathyroidism, pseudohypoparathyroidism, chronic liver failure, extrapontine myelinolysis, end-stage kidney disease with diabetes, type 2 diabetes | |||
Structural | Normal pressure hydrocephalus, chronic subdural hematoma, tumors involving striatonigral circuits, head trauma | |||
Infectious | Encephalitis lethargica, HIV/AIDS, neurosyphilis, prion disease, progressive multifocal leukoencephalopathy, toxoplasmosis | |||
Genetic | Wilson disease, neurodegeneration with brain iron accumulation, neuroacanthocytosis |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟